Phio pharmaceuticals fintel
WebbPhio Pharmaceuticals Corp. is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™) … WebbPHIO / Phio Pharmaceuticals Corp - Net Long/Short Value This page provides the net long/short valuations for each institutional holding reported via 13F or NPORT filings. To …
Phio pharmaceuticals fintel
Did you know?
WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAI technology makes immune cells more effective in killing tumor cells. INTASYL is the only self-delivering RNAi technology focused on immuno-oncology therapeutics. WebbAll rights reserved. Fintel® is a registered trademark. Privacy Policy; Terms and Conditions; This website is provided “as is” without any representations or warranties, express or …
WebbDeutsche Bank Ag\ closes position in PHIO / Phio Pharmaceuticals Corp Institutional Ownership: 13F and NPORT Filings The Security and Class in the table below are shown … WebbPhio Pharmaceuticals Corp (NASDAQ:PHIO) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in …
Webb10 apr. 2024 · Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. About the company Risk Analysis Earnings have declined by 8.5% per year over past 5 years Has less than 1 year of cash runway Makes less than USD$1m in revenue ($0) Does not have a meaningful market cap ($7M) + 2 more risks See All Risk Checks … WebbPhio Pharmaceuticals Corp. 257 Simarano Drive, Suite 101 Marlborough, MA 01752 (508) 767-3861 February 7, 2024 VIA EDGAR Securities and Exchange Commission Division of …
WebbPHIO / Phio Pharmaceuticals Corp Implied Volatility - Fintel Labs. Fintel ...
Webb359 rader · Phio Pharmaceuticals Corp insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is … daisy mints seat cushion reviewWebbPhio Pharmaceuticals Contact Us Contact Us Get in touch with us. General inquiries: [email protected] Investor relations information: [email protected] Employment opportunities: [email protected] Business development inquiries: [email protected] 257 Simarano Dr Marlborough, MA 01752 biotech biological grid fish filterWebbThe average one-year price target for Phio Pharmaceuticals is $73.44 The forecasts range from a low of $72.72 to a high of $75.60. Update Frequency: Monthly PHIO / Phio … biotech biomass boilerWebb7 nov. 2024 · Phio Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its... PhioPharma @phio_pharma · May 3, 2024 daisy mountain animal clinicWebbPHIO Stock Financial Analysis - Phio Pharmaceuticals Corp (NASDAQ) Stock. Fintel ... biotech bonds flashcardsWebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology makes immune cells more effective in … daisy mountain post office passportWebb1 mars 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™) therapeutic... biotech blood